Brief: Theranexus FY Net Operating Loss Narrows To EUR 6.1 Mln
April 7 (Reuters) - THERANEXUS SA ALTHX.PA :
* 2020 FULL-YEAR RESULTS
* COMPANY'S CASH AMOUNTED TO €10,773 K AT 31 MARCH 2021,
AGAINST
€11,212 K AT 31 DECEMBER 2020
* NET OPERATING LOSS NARROWED TO -€6,099 K IN 2020
* FY OPERATING INCOME EUR 0.3 MILLION VERSUS EUR 0.6 MILLION
YEAR
AGO
* FY NET LOSS EUR 4.8 MILLION VERSUS LOSS EUR 5.6 MILLION
YEAR AGO
Source text for Eikon: ID:nNDLZtj7g
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease